The epidemiology of dysthymia in five communities: rates, risks, comorbidity, and treatment.
about
Drugs versus placebo for dysthymiaDrugs versus placebo for dysthymiaPharmacotherapy for dysthymiaDysthymic disorder: forlorn and overlooked?Adding group psychotherapy to medication treatment in dysthymia: a randomized prospective pilot studyWorld Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 2: Maintenance treatment of major depressive disorder and treatment of chronic depressive disorders and subthreEffect of concurrent anxiety on response to sertraline and imipramine in patients with chronic depression.The Zurich Study. XII. Sex differences in depression. Evidence from longitudinal epidemiological data.Mindfulness-based cognitive therapy as a treatment for chronic depression: A preliminary study.Recognition and treatment of dysthymia in elderly patients.Efficacy and tolerability of venlafaxine in the treatment of primary dysthymia.Dysthymia: a review of pharmacological and behavioral factors.Surviving social assistance: 12-month prevalence of depression in sole-support parents receiving social assistance.Proposed endophenotypes of dysthymia: evolutionary, clinical and pharmacogenomic considerations.An open treatment trial of duloxetine in elderly patients with dysthymic disorder.Tachyphylaxis/tolerance to antidepressants in treatment of dysthymia: results of a retrospective naturalistic chart review study.World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders in Primary Care.The STAR*D Project results: a comprehensive review of findings.Breaking the myths: new treatment approaches for chronic depression.Four cases of dysthymic disorder and general malaise successfully treated with traditional herbal (kampo) medicines: kamiuntantoClinical features of patients with dysthymia in a large cohort of Han Chinese women with recurrent major depression.Dysthymia and apathy: diagnosis and treatment.Ethnically diverse mothers' views on the acceptability of screening for maternal depressive symptoms during pediatric well-child visits.The epidemiology of chronic major depressive disorder and dysthymic disorder: results from the National Epidemiologic Survey on Alcohol and Related ConditionsA comparison of the clinical characteristics of Chinese patients with recurrent major depressive disorder with and without dysthymia.Epidemiology of depression.Efficacy of add-on deep transcranial magnetic stimulation in comorbid alcohol dependence and dysthymic disorder: three case reports.The role of specialised units in the treatment of affective disorders.The prevalence and impact of risk factors for ethnic differences in loneliness.Antidepressants normalize the default mode network in patients with dysthymia.General health, health care utilization, and medical comorbidity in dysthymia.Risk factors for the onset of depression in middle age and later life.Epidemiology of affective disorders: a review.Evidence for neuroplastic compensation in the cerebral cortex of persons with depressive illness.Self-reported chronic mental health problems and mental health service use in Spain.Dysthymia among the community-dwelling elderly.Lifetime course of chronic depression in older men.Aging and attentional biases for emotional faces.Aging, emotion, and evolution: the bigger picture.Dysthymic disorder.
P2860
Q24187378-1D1FC207-FEB4-497B-BF6B-5847ADB291DBQ24246945-AE35A2CB-3A01-4B5E-82DD-6C7781AC53E4Q24247920-D90C391F-C698-43D9-9449-267B120CA5F8Q24658238-9A4511C7-ED4D-419C-A747-6C7170512238Q28361262-E313C6A9-3EB1-45F0-9844-417D2BB57F29Q31121202-305D1D45-AC35-4DAD-96C5-C197DE956BC8Q32097605-813FB1F0-85B3-440A-BB73-334F4FF03379Q33212784-51C8FB38-E336-4E63-82DD-7BAEBDB034B9Q33836240-606C1AD2-F2A4-4FA9-8B00-6D78BBB663F8Q33885918-0AE01544-EBC1-425F-AEFB-B38C6660A5A1Q33922140-0B893150-0E50-4263-B091-463C38EA64F8Q33964349-DE59B4E1-4AE7-421F-808E-1FFF227F6012Q34028274-8EA18E2B-B107-4E0F-9125-9CB91A839CD6Q34083327-C4FBED1A-411F-441A-BFC4-BCA964547A13Q34093154-DDA425BA-397F-41AB-941F-8FB083344C7DQ34208946-05C39319-E634-4BEE-B54C-6D01E5F9C227Q34578945-E84DBAE2-3BD0-4532-B54C-28125B161643Q34741960-F6E1AA7F-8A3B-4ADD-9661-49974220EB4BQ34923254-C5CAC4E2-2BE4-4006-99B4-FE3781515527Q34983165-DBE33538-C9B3-4E25-91CD-79BFE8A448A6Q35080425-D7287D33-684F-4154-BFE9-EA6A53D18D1FQ35089933-58C1014F-DD0D-4C7F-B8F2-FD83ED2EF056Q35210738-1F8138A3-F9DA-4FDA-A081-A71942B714DDQ35458096-E3968BF5-9353-4D11-B710-5E9EBBCB49F2Q35564126-FA82C06C-1E5C-470D-8823-B851C6729DA9Q35906856-891B5995-B7C9-4AA9-9282-866C4BA49189Q36866791-3B51D32E-A3A3-47FA-AEE6-34E05C47AC1AQ36969985-6AE258BD-36F3-4F4B-99D3-1E6AE717E3A3Q37519786-D6025C06-E77F-4215-9367-A253D21B9864Q37604965-B60202FF-1646-45F3-8DB0-4012F3E6AF2EQ40795663-E57AE5B3-BFAA-4033-86D9-B0FFC7DA5CF2Q41074000-B38BA54F-68DA-497B-86ED-811E867E03A2Q41479704-7DA8FEF1-561D-49C6-9D43-A7CB356749E7Q41557799-B87B33D5-5DF2-4BEE-8094-7B2749037216Q43614295-8A18BC0F-58F4-43E9-B2B6-2DE8AB7544D5Q44559795-AD4C8EB1-9DC0-41FD-BCC2-05C3E3E8B05FQ45830983-DBEFDAE8-3DA8-4210-B5D0-4D9AA968C5FEQ46040423-707EAB7D-2EE3-43E8-9BE6-237D2617BF15Q46111000-104BD97F-5452-44F2-BB7C-F6B66810F797Q50068457-D6481D4F-6F25-40D6-A5A3-C523513D79BA
P2860
The epidemiology of dysthymia in five communities: rates, risks, comorbidity, and treatment.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年学术文章
@wuu
1988年学术文章
@zh-cn
1988年学术文章
@zh-hans
1988年学术文章
@zh-my
1988年学术文章
@zh-sg
1988年學術文章
@yue
1988年學術文章
@zh
1988年學術文章
@zh-hant
name
The epidemiology of dysthymia ...... s, comorbidity, and treatment.
@en
The epidemiology of dysthymia ...... s, comorbidity, and treatment.
@nl
type
label
The epidemiology of dysthymia ...... s, comorbidity, and treatment.
@en
The epidemiology of dysthymia ...... s, comorbidity, and treatment.
@nl
prefLabel
The epidemiology of dysthymia ...... s, comorbidity, and treatment.
@en
The epidemiology of dysthymia ...... s, comorbidity, and treatment.
@nl
P2093
P356
P1476
The epidemiology of dysthymia ...... s, comorbidity, and treatment.
@en
P2093
P304
P356
10.1176/AJP.145.7.815
P407
P577
1988-07-01T00:00:00Z